Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
19/10/2026
GlaxoSmithKline's B7-H3-targeted antibody-drug conjugate Ris-Rez achieved a 61% objective response rate in lung cancer clinical trials.
Latest
12 m ago
Samsung Electronics and SK Hynix fell more than 5% in pre-market trading on Nextrade.
12 m ago
A-share dividend, buyback, and shareholding increase wave surges as listed companies solidify the foundation for value investing.
13 m ago
First batch of fund Q3 2026 reports disclosed; fund managers optimistic about long-term performance of equity assets.
13 m ago
Saudi Arabia and Yemen's Houthi forces continue to attack each other.
13 m ago
Embodied intelligence data industry explodes, data assets usher in value revaluation.
See all latest
